Completing an initial public offering ought to be a big step in company development. It is a departure from a cosseted, insulated environment of unique technical approaches and regulatory progress and
If there’s a theme to many of the top stories of the past year it’s infrastructure—the crisis of owning too much and the economic power of leveraging someone else’s. By Windhover’s Biopharma Team Last